Medtech Money Flow: M&A And VC Deals, Sept. 17 - 23, 2018
Executive Summary
Find out where the medtech money is flowing in our weekly roundup. Among other deals, Medtronic makes a mammoth acquisition to buy the remaining shares of Israeli surgical robotics firm Mazor Robotics and Israeli company MeMed secures $70m to advance its point-of-care immune system diagnostic for distinguishing between bacterial and viral infections.
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.